A detailed history of Redmile Group, LLC transactions in Absci Corp stock. As of the latest transaction made, Redmile Group, LLC holds 8,253,316 shares of ABSI stock, worth $32.8 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
8,253,316
Previous 8,253,316 -0.0%
Holding current value
$32.8 Million
Previous $46.9 Million 45.77%
% of portfolio
1.66%
Previous 1.85%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $757,777 - $1.28 Million
222,222 Added 2.77%
8,253,316 $46.9 Million
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $83.3 Million - $243 Million
8,031,094 New
8,031,094 $93.4 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $369M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.